Metabolically Healthy Obesity
Open accessThe DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index.
Abstract
Obesity contributes to reduced life expectancy, impaired quality of life, and disabilities, mainly in those individuals who develop cardiovascular diseases, type 2 diabetes, osteoarthritis, and cancer. However, there is a large variation in the individual risk to developing obesity-associated comorbid diseases that cannot simply be explained by the extent of adiposity. Observations that a proportion of individuals with obesity have a significantly lower risk for cardiometabolic abnormalities led to the concept of metabolically healthy obesity (MHO). Although there is no clear definition, normal glucose and lipid metabolism parameters—in addition to the absence of hypertension—usually serve as criteria to diagnose MHO. Biological mechanisms underlying MHO lower amounts of ectopic fat (visceral and liver), and higher leg fat deposition, expandability of subcutaneous adipose tissue, preserved insulin sensitivity, and beta-cell function as well as better cardiorespiratory fitness compared to unhealthy obesity. Whereas the absence of metabolic abnormalities may reduce the risk of type 2 diabetes and cardiovascular diseases in metabolically healthy individuals compared to unhealthy individuals with obesity, it is still higher in comparison with healthy lean individuals. In addition, MHO seems to be a transient phenotype further justifying therapeutic weight loss attempts—even in this subgroup—which might not benefit from reducing body weight to the same extent as patients with unhealthy obesity. Metabolically healthy obesity represents a model to study mechanisms linking obesity to cardiometabolic complications. Metabolically healthy obesity should not be considered a safe condition, which does not require obesity treatment, but may guide decision-making for a personalized and risk-stratified obesity treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Hyperplasia, referring to an increase in the number of adipocytes, is associated with an increase in subcutaneous fat volume and protective signals, and is associated with MHO (50).”
From Metabolic impact of endogenously produced estrogens by adipose tissue in females and males across the lifespan (2025) · cites this paper as [50]
The cited source says what the claim attributes to it.
In the citing paper
“On the contrary, hypertrophic adipocytes, in which existing adipocytes enlarge, is associated with increased dysfunction and MUHO (50), which contributes to IR and subsequent T2D (52, 53).”
From Metabolic impact of endogenously produced estrogens by adipose tissue in females and males across the lifespan (2025) · cites this paper as [50]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Marso, S. P., Daniels, G. H., Brown-Frandsen, K., Kristensen, P., Mann, J. F. E., Nauck, M. A., Nissen, S. E., Pocock, S., Poulter, N. R., Ravn, L. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603827 · Cited by 7,629
Abarca-Gómez, L., Abdeen, Z. A., Hamid, Z. A., Abu-Rmeileh, N. M., Acosta-Cazares, B., Acuin, C., Adams, R. J., Aekplakorn, W., Afsana, K., Aguilar-Salinas, C. A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32129-3 · Cited by 7,482
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Marso, S. P., Bain, S. C., Consoli, A., Eliaschewitz, F. G., Jódar, E., Leiter, L. A., Lingvay, I., Rosenstock, J., Seufert, J., Warren, M. L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1607141 · Cited by 6,900
Obesity: global epidemiology and pathogenesis
Blüher, M. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0176-8 · Cited by 5,126
Self-citationThe global obesity pandemic: shaped by global drivers and local environments
Swinburn, B. A., Sacks, G., Hall, K. D., McPherson, K., Finegood, D. T., Moodie, M. L., & Gortmaker, S. L. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60813-1 · Cited by 4,888
Cited by
Items 701–800 of 999
Ellison, K. M., Zein, A. E., Reynolds, C., Ehrlicher, S. E., Clina, J. G., Chui, T. K., Smith, K. A., Hill, J. O., Wyatt, H. R., & Sayer, R. D. (2024) · Nutrients · doi:10.3390/nu16172874 · Cited by 1
Khakbaz, M., Poursalehi, D., Mirzaei, S., Asadi, A., Akhlaghi, M., & Saneei, P. (2024) · British Journal Of Nutrition · doi:10.1017/s0007114524002381 · Cited by 3
“Excess weight is often associated with abnormalities in metabolic health, but some individuals with overweight/obesity have a healthy metabolic profile (6) .”
BackgroundInfluentialWang, Y., Chen, D., Pu, Y., Shi, J., Yi, C., Chen, J., Yang, G., Cui, Y., Nie, Y., Zhang, L., et al. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.123306 · Cited by 4
Obesity and postpartum hospital use among individuals without additional medical comorbidities
Glazer, K. B., Janevic, T. M., Boychuk, N., Egorova, N., Hebert, P. L., Zeitlin, J. A., & Howell, E. A. (2024) · Obesity · doi:10.1002/oby.24167 · Cited by 2
“Moreover, research in the general population has advanced understanding of obesity subtypes such as metabolically healthy versus meta-bolically unhealthy [9]; however, similar investigations in pregnancy and the postpartum period are scarce.”
Guo, L., Pan, Y., Yang, Y., Kong, X., Song, S., Li, M., Zhao, Y., Ma, X., Wang, X., & Sun, Q. (2025) · International Journal of Obesity · doi:10.1038/s41366-025-01723-7 · Cited by 1
“However, some people are diagnosed with obesity yet no metabolic disorders, a condition termed metabolically healthy obesity (MHO) [10].”
Bustamante-Rodríguez, J. C., Zuzunaga-Montoya, F. E., Ballena-Caicedo, J., Valladolid-Sandoval, L. A. M., Vásquez-Romero, L. E. M., Loayza-Castro, J. A., Carrillo, C. I. G. D., & Vera-Ponce, V. J. (2025) · Nutrición clínica y dietética hospitalaria/Nutrición clínica, dietética hospitalaria · doi:10.12873/451bustamante · Cited by 1
Ebrahimi, S., Shiraseb, F., Ladaninezhad, M., Izadi, A., Navaei, N., & Mirzaei, K. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1490937 · Cited by 2
Zimmermann, S., Roomp, K., Meyer, H., Mathew, A., Struck, M. F., Blüher, M., Martin, H. N. G., Keller, M., Landgraf, K., Körner, A., et al. (2025) · Journal of Diabetes · doi:10.1111/1753-0407.70083 · Cited by 1
“All laboratory measurements were performed concurrently [38, 39].”
Self-citationKazeminasab, F., Baharlooie, M., Bagheri, R., Rosenkranz, S. K., & Santos, H. O. (2025) · European Journal of Clinical Nutrition · doi:10.1038/s41430-025-01626-w · Cited by 2
The interplay of depressive symptoms, adiposity, and metabolic markers in young adults
Naude, D., Smith, W., & van Vuren, E. J. (2025) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2025.107521 · Cited by 2
“…transitional metabolic phase in depressive symptomatology where individuals who are overweight (specifically metabolically healthy) might exhibit better health outcomes compared to those who are underweight or metabolically unhealthy obese (Blüher, 2020; Flegal et al., 2005; Hinnouho et al., 2017).”
Blüher, M. (2025) · Herz · doi:10.1007/s00059-025-05321-1 · Cited by 1
“Up to one fourth of people with obesity may be protected against premature cardiometabolic dis-easemanifestations,anobesityphenotype that has been described as “metabolically healthy obesity” [26].”
Self-citationHagemann, T., Rolle-Kampczyk, U. E., Schubert, K. A., Dietrich, A., von Bergen�, M., Blüher, M., & Hoffmann, A. (2025) · Environmental Advances · doi:10.1016/j.envadv.2025.100655 · Cited by 1
Self-citationEvaluation of irisin levels and lipid profiles in obese men with type 2 diabetes mellitus
Al-Taie, D. T., & Adlan, M. M. (2025) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.21.4.2025.1568 · Cited by 1
Baek, S., & Yoon, J. (2025) · Journal of Exposure Science & Environmental Epidemiology · doi:10.1038/s41370-025-00789-9 · Cited by 1
Zeng, Z., & Xiao, Z. (2025) · BMC Public Health · doi:10.1186/s12889-025-23868-w · Cited by 4
“While our study did not directly compare the transitions between cardiometabolic statuses, evidence suggests that individuals initially classified as RHC or MetS may develop the other phenotype over time [33, 34].”
Cheon, B. K., Bittner, J. M. P., Smith, M. R., & Chen, Z. (2025) · BMC Public Health · doi:10.1186/s12889-025-24254-2 · Cited by 2
“MHO may not only be a valuable model for understanding how excess adiposity generates cardio-metabolic complications through physiological mechanisms [24], but also through psychosocial ones.”
Shad, E., Azadikhah, F., Shekarforoush, S. S., Nazıfı, S., & Eskandari, M. H. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10743-8 · Cited by 1
Association Between Body Composition and Obesity Phenotypes in Children and Adolescents
Deng, Y., Chen, M., Huang, Z., Liang, X., Pan, S., Ji, J., Zhang, Z., Long, J., & Liu, L. (2025) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.70055 · Cited by 1
Valle, M. M., Robledo, A., O’Leary, S., Basurto, L., Maldonado, E. R., Gaspar-Gurza, J. M., Rosales-Cruz, É., Vega-García, S., & Murillo, C. M. (2025) · International Journal of Obesity · doi:10.1038/s41366-025-01915-1 · Cited by 1
“Interestingly, those classi fi ed as individuals with metabolically healthy obesity (MHO) have shown links to cardiovascular disease, mortality, and metabolic disorders, challenging their classi fi cation [5].”
Machlik, M. L., Grimsgaard, S., Hopstock, L. A., Jacobsen, B. K., & Lundblad, M. W. (2025) · PLoS ONE · doi:10.1371/journal.pone.0333402 · Cited by 2
Association between dietary intake and the expression of clock genes in adults: a brief report
Lages, M., Barros, R., Ferreira‐Marques, M., Correia, J., Caseiro, A., Guarino, M. P., & Carmo‐Silva, S. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1663559 · Cited by 1
“Participants within the same BMI group may exhibit distinct phenotypes despite similar body weight classifications (62).”
Zhong, F., Feng, J., Zhang, L., Lin, L., Yuan, H., Li, J., Tian, T., & Hu, Y. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1591300 · Cited by 2
Perspective on Epicardial Adipose tissue
Upadhaya, S., Samson, R., & Jemtel, T. H. L. (2025) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2025.106559 · Cited by 2
Pariès, M., Teiti, I., Aubry, M., Patin, É., Madec, Y., Chung, K., Boucheron, P., Lastère, S., Etoundi, M., Paoaafaite, T., et al. (2025) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2025.101746 · Cited by 1
“26 Importantly, the MHO phenotype should not be considered benign or exempt from intervention, as it carries elevated cardiometabolic risk compared to metabolically healthy non-obese individuals.”
Wu, X., Zhang, R., Gan, S., Zhou, H., Yu, F. F., & Luo, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-30646-6 · Cited by 1
“…that normal BMI equates to metabolic health, revealing the existence of subclinical metabolic dysfunction among apparently healthy individuals 27,28 integrating age, sex, and BMI information, provides a more refined assessment of body fat distribution, effectively identifying individuals who…”
Jeon, B.-J., Lee, J., Kwon, D.-H., Kim, H.-K., & Jang, G. (2025) · PLoS ONE · doi:10.1371/journal.pone.0311478 · Cited by 3
Pepe, A., Arani, A. A., Bracone, F., Castelnuovo, A. F. D., Muñoz-Venegas, L., Cerletti, C., de Gaetano, G., Donati, M. B., Iacoviello, L., & Gialluisi, A. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1616303 · Cited by 3
“Adapted from Blüher (2020), Gómez-Zorita et al. (2021), Primeau et al. (2011). markers.”
Krautbauer, S., Weber, F., Liebisch, G., & Buechler, C. (2026) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2026.105029 · Cited by 1
Poothullil, J. M. (2026) · Medical Hypotheses · doi:10.1016/j.mehy.2026.111926 · Cited by 1
Kim, J. H., Yim, Y., Yoo, H., Kim, H., Woo, S., Hwang, Y., & Yon, D. K. (2026) · Medicine · doi:10.1097/md.0000000000047797 · Cited by 1
“MUHO, [24] characterized by the coexistence of obesity and metabolic abnormalities, is associated with chronic low-grade inflammation, insulin resistance, and endothelial dysfunction, all of which may be exacerbated in older adults, rural residents, and those with lower socioeconomic status due to…”
Sakizlian, D. D. M., Ciobanu, D., Boldeanu, L., Assani, M.-Z., Siloşi, I., Pădureanu, V., Caragea, D. C., Dinescu, V. C., & Plasiciuc, A. E. C. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27062558 · Cited by 1
Fei, H., Pang, J., Su, P., Li, S., Zhang, Y., Liu, Z., Zhang, C., Jia, H., & Chi, W. (2026) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2026.104721 · Cited by 1
Alharbi, A. S. (2026) · Healthcare · doi:10.3390/healthcare14081046 · Cited by 1
Wang, K., Zhang, T., & Lin, Y. (2026) · BMC Cardiovascular Disorders · doi:10.1186/s12872-026-05849-y · Cited by 1
Challenges and promises of nutritional epidemiology to investigate cancer etiology
Ferrari, P., Loftfield, E., Papier, K., Huybrechts, I., & Freisling, H. (2026) · JNCI Monographs · doi:10.1093/jncimonographs/lgag004 · Cited by 1
Buchold, J., Meyer, H., Struck, M. F., Kohli, S., Mathew, A., Mangova, G., Surov, A., Blüher, M., Isermann, B. H., & Zimmermann, S. (2026) · Obesity Reviews · doi:10.1111/obr.70137 · Cited by 1
Self-citationObesity, inflammation, and the Mediterranean diet in cancer
Chapela, S. P., Sarno, G., Niño, C., Brachi, M. P., Cucalón, G., BASTIDAS, S., Saettone, F., Toral-Noristz, M., Galasso, M., & Verde, L. (2026) · Food and Agricultural Immunology · doi:10.1080/09540105.2026.2668199 · Cited by 1
Cai, Y., Jin, J., Wang, Y., Han, D., Yu, X., Jin, F., Li, M. D., Li, Y., & Li, X. (2026) · BMC Medicine · doi:10.1186/s12916-026-04898-6 · Cited by 2
Cheraghian, B., Moftakhar, L., Shahriari, A., & Rahimi, Z. (2026) · Scientific Reports · doi:10.1038/s41598-026-52895-9 · Cited by 1
Aunbakk, N., Bøhn, S. K., Laupsa‐Borge, J., Sommersten, C. H., McCann, A., Lied, G. A., Nygard, O. K., Dierkes, J., Mellgren, G., Dankel, S. N., et al. (2026) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00499.2025 · Cited by 1
Perspective Chapter: Beyond BMI – Rethinking Obesity Assessment in Women’s Health
GÜRBÜZ, T., & Gökmen, O. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1012799 · Cited by 2
Pathogenesis of Lipedema: A Hypothesis-Generating Model of Regenerative Imbalance in Adipose Tissue
Sandhofer, M., Hanke, C. W., Barsch, M., & Faulhaber, J. (2026) · Journal of Aesthetic Medicine · doi:10.3390/jaestheticmed2020010 · Cited by 1
Adiposity and cancer: epidemiology, mechanisms and future perspectives
Watts, E. L., Gonzalez‐Feliciano, A. G., Gunter, M. J., Chatterjee, N., & Moore, S. C. (2026) · Nature Metabolism · doi:10.1038/s42255-026-01529-5 · Cited by 4
“These individuals may have lower cancer risks compared with their metabolically unhealthy counterparts, although risk remains higher than in those who are metabolically healthy and lean 11,59 .”
InfluentialMacronutrient mixtures and interactions in health and disease
Simpson, S. J., Couteur, D. G. L., Small, L., Brandon, A. E., & Raubenheimer, D. (2026) · Nature Reviews Endocrinology · doi:10.1038/s41574-026-01266-5 · Cited by 3
“However, although adiposity and metabolic risk can be partially uncoupled, metabolically healthy obesity is often transient and associated with long-term elevated health risk 105 .”
Does metabolically healthy obesity really exist: going toward new definitions
Rodriguez, C., & Ravussin, É. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag247 · Cited by 2
Tomé‐Carneiro, J., Cepeda-Vidal, T., Valdés, A., Colás‐Ruiz, N. R., Cruz, E. F., Álvarez, M. B., Matía-Martín, P., & Martínez, J. A. (2026) · European Journal of Nutrition · doi:10.1007/s00394-026-04047-y · Cited by 1
“The paradigm of metabolically healthy excess weight (BMI ≥ 25), affecting approximately 10–30% of individuals with elevated BMI [10 , 11 ], under - scores the importance of metabolic biomarkers that reflect dietary quality independent of body weight.”
Abdallah, H., Khalil, M., Mahdi, L., Pietragalla, G., Faienza, M. F., Garruti, G., & Portincasa, P. (2026) · Nutrients · doi:10.3390/nu18142317 · Cited by 1
“This suggests that even in the absence of overt metabolic dysfunction, obesity can negatively impact quality of life and health outcomes [52].”
Ke, J., Zhang, Y., Shao, X., Tan, Z., Bai, G., Ju, J., Chen, H., Wang, Z., & Zhang, J. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.71112 · Cited by 5
“Notably, higher metabolic scores remained associated with greater CRM multimorbidity risk among individuals with normal BMI, consistent with the concept that normal body weight does not necessarily indicate metabolic health [25–27].”
Trends in Diagnosing Obesity: The CALOR Study
Horn, D. B., Lesén, E., Gray, C. M., Bjursell, M. K., & Waki, H. (2026) · Obesity · doi:10.1002/oby.70264 · Cited by 2
“…variance with the concepts of “metabolically healthy obesity” and “preclinical obesity” (a term used in some frameworks), which are characterized by a state of excess adiposity but a lower risk of interrelated diseases, although the risk is still higher than in healthy, lean individuals [13, 37].”
Xu, Y., & Yang, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1901774 · Cited by 2
“…resistance, dyslipidemia, hypertension, or systemic in fl ammatory abnormalities, whereas metabolically unhealthy obesity (MUO) is characterized by visceral adiposity, insulin resistance, adipose tissue in fl ammation, ectopic lipid deposition, and a more pronounced proin fl ammatory milieu (33, 34).”
Qiang, Z., Wang, Y., Li, Y., & Li, Y. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1907694 · Cited by 1
Ruga, S., Matarese, E., Bava, R., Lombardi, C., Dimatteo, T., Miscio, L., Raponi, M., Giordano, A., Sansone, C., Liguori, G., et al. (2026) · Pharmaceuticals · doi:10.3390/ph19081230 · Cited by 1
Kim, S. R., Cho, D., Kim, M., Cha, J., Kim, B. R., Yang, J. H., & Park, S. (2026) · Cardiac failure review · doi:10.15420/cfr.2026.16 · Cited by 1
Metabolic flexibility in mammalian hibernation
Bertile, F. (2026) · Cahiers de Nutrition et de Diététique · doi:10.1016/j.cnd.2026.07.004 · Cited by 1
Patil, P., Lalwani, P., Vidwans, H., Kulkarni, S., Bais, D., Diwekar-Joshi, M., Rasal, M., Bhasme, N., Naik, M., Batwal, S., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0245093 · Cited by 1
“The distribution of fat is claimed to be different in the metabolically healthy obese [12].”
BackgroundWang, H., Xia, F., Ren, Q., Zeng, Y., Tan, X., Ye, T., Fan, J., & Xu, Y. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.857841 · Cited by 2
Integrated Care Model of Adiposity-Related Chronic Diseases
Jemtel, T. H. L., Samson, R., & Oparil, S. (2022) · Current Hypertension Reports · doi:10.1007/s11906-022-01223-3 · Cited by 1
Özdemir, F., Açmaz, B., Açmaz, G., Müderris, İ. İ., & Mıstık, S. (2022) · Online Türk Sağlık Bilimleri Dergisi · doi:10.26453/otjhs.1168651 · Cited by 1
La obesidad y su relación con el consumo de probióticos
Rodríguez-Reyes, X. J., Alanís‐García, E., Delgado‐Olivares, L., & Cruz‐Cansino, N. D. S. (2022) · Educación y Salud Boletín Científico Instituto de Ciencias de la Salud Universidad Autónoma del Estado de Hidalgo · doi:10.29057/icsa.v11i21.9669 · Cited by 4
de Aguilar-Nascimento, J. E., Caporossi, C., Metelo, J. S., Tanajura, G., Canevari-de-Oliveira, M., & Costa, R. D. C. (2014) · Nutrición Hospitalaria · doi:10.20960/nh.04451 · Cited by 13
Patients using real-time remote health monitoring applications
Butt, S. A., Ali, A., Khalid, A., Shaheen, Q., Ariza-Colpas, P., & Shiraz, M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99421-7.00016-7 · Cited by 1
Кузнецова, А. С., Dolgushina, A. I., Pospelov, V. V., Sokolova, T. A., Лебедев, Е. В., & Genkel, V. V. (2023) · The Russian Archives of Internal Medicine · doi:10.20514/2226-6704-2023-13-3-196-202 · Cited by 1
Zhang, W., Du, J., Dong, H., Cheng, Y., Zhong, F., Yuan, Z., Dong, Y., Wang, R., Mu, S., Zhao, J., et al. (2023) · Archives of Medical Research · doi:10.1016/j.arcmed.2023.102840 · Cited by 2
The Chronically Inflamed (Obese) Horse: Understanding Adipose Biology
Hollands, T. (2023) · CABI eBooks · doi:10.1079/9781789245134.0015 · Cited by 1
Understanding Obesity and Setting the Stage for Comprehensive Treatment
Fox, C. K., & O’Hara, V. M. (2023) · Springer eBooks · doi:10.1007/978-3-031-37380-0_1 · Cited by 1
Ramachandra, S. C., Prashant, A., Shivanna, A., Bhujanga, A. K., Meherunnisa, S., & Vishwanath, P. (2023) · International Journal of Health & Allied Sciences · doi:10.55691/2278-344x.1058 · Cited by 1
Xiang, H., Dong, D., Lv, L., & Tao, X. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.1003616 · Cited by 1
Koçak, B., Emirhüseyinoğlu, A., & Alphan, M. E. (2023) · Atlas Universitesi Tip ve Saglik Bilimleri Dergisi · doi:10.54270/atljm.2023.44 · Cited by 2
Gupta, R., Sharma, K. K., Khedar, R. S., Sharma, S., Makkar, J. S., Bana, A., Natani, V., Bharati, S., Kumar, S., Hadiya, V. M., et al. (2023) · International Journal of Cardiology Cardiovascular Risk and Prevention · doi:10.1016/j.ijcrp.2023.200230 · Cited by 4
Al-shibli, R. H., Yousif, A. C., & Jaafar, A. Q. (2024) · Journal of Scientific Research in Medical and Biological Sciences · doi:10.47631/jsrmbs.v4i4.656 · Cited by 1
Vitamin D and the Metabolic Phenotype in Weight Loss After Bariatric Surgery: A Longitudinal Study
da Cruz, S. P., da Cruz, S. P., Pereira, S., Saboya, C. J., & Ramalho, A. (2024) · Obesity Surgery · doi:10.1007/s11695-024-07148-x · Cited by 1
“These conditions make up a metabolic risk profile, characterized by imbalances in cardiometabolic and inflammatory parameters, which is known as meta-bolically unhealthy obesity (MUHO) [7, 8].”
Bae, S., Kang, S., Ko, H., Park, J., & Jun, W. (2024) · Journal of Medicinal Food · doi:10.1089/jmf.2023.k.0299 · Cited by 1
Mendonça, F. M., Soares, P., Moreno, T., Freitas, P., Rodrigues, I., Silva, D. F., Pedro, J. M. P., Varela, A. T. I. F., Fernandes, A. R., Fernandes, R., et al. (2024) · International Journal of Obesity · doi:10.1038/s41366-024-01519-1 · Cited by 2
Vázquez-Carrillo, D. I., Ocampo-Ruiz, A. L., Baez, A., Ramírez‐Hernández, G., Adán‐Castro, E., García-Rodrigo, J. F., Dena-Beltrán, J. L., Ríos, E. A. D. L., Sánchez-Martínez, M. K., Ortiz, M. G., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0301496 · Cited by 1
Soleimanifar, M., Abedi, M., Sarabzadeh, M., Dadarkhah, A., & Asadi, Z. S. (2024) · Jundishapur Journal of Health Sciences · doi:10.5812/jjhs-144460 · Cited by 1
Wadden, K. P., Hollohan, N., Furneaux, T., Maher, R., Barrett, C. M., Fuller, D., Basset, F., Murphy, D., Murphy, S., Healey, S., et al. (2024) · Frontiers in Sports and Active Living · doi:10.3389/fspor.2024.1332376 · Cited by 2
“In disease-speci fi c populations such as diabetes, shifting the focus from weight loss to metabolism has resulted in the development of innovative and ef fi cacious methodologies to advance our understanding of “ metabolically healthy obesity ” (24).”
BackgroundSalehi, M., Esfarjani, F., & Firoozjaei, S. G. (2023) · doi:10.32592/jsmj.22.4.483 · Cited by 1
Baniasad, A., Najafzadeh, M. J., Najafipour, H., & Gozashti, M. H. (2024) · Clinical Obesity · doi:10.1111/cob.12691 · Cited by 1
“Some studies have considered MHO a benign phenotype, 9,10 while some others have indicated a higher risk for MHO individuals than for metabolically healthy non-obese individuals, in terms of developing cardiovascular diseases, 1,7,11 diabetes 12 and mortality.”
Evaluation of weight loss and quality of life in long-term post-bariatric surgery
Péres, A., Bernhardt, J., & Tibolla, V. (2024) · Metabolism and Target Organ Damage · doi:10.20517/mtod.2023.60 · Cited by 1
Liu, Q., Yao, T., Chen, Y., Xiao, F., Wu, Y., & Dai, H. (2024) · Medicine · doi:10.1097/md.0000000000039621 · Cited by 1
“[48] And it was thought that MHO had a lower risk to develop to CVD, compared to metabolically unhealthy obesity but higher than metabolically healthy lean people.”
BackgroundMoraes, L. R. D. S., dos Santos, N. Q., Marques, D. C. D. S., Marques, M. G. D. S., Lalucci, M. P. D. P. S., Perli, V. A. S., Aizava, P. V. S., Hernández-Martínez, J., Valdés-Badilla, P. A., & Branco, B. H. M. (2024) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph21111406 · Cited by 1
Metabolic Phenotype and Risk of Obesity-Related Cancers in the Women’s Health Initiative
Karra, P., Hardikar, S. S., Winn, M., Anderson, G. L., Haaland, B. A., Shadyab, A. H., Neuhouser, M. L., Seguin‐Fowler, R. A., Thomson, C. A., Coday, M., et al. (2024) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-24-0082 · Cited by 2
Cmpk2 Gene and Protein Expression in Saliva or Salivary Glands of Dyslipidemic Mice
Zhang, B., Kawamoto, A., Nakagawa, M., Honda, Y., & Takahashi, K. (2024) · Applied Sciences · doi:10.3390/app142412004 · Cited by 3
Sater, M. S., Malalla, Z. H. A., Ali, M. E., & Giha, H. A. (2025) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph22020207 · Cited by 1
Controversies and challenges of anticoagulation therapy in obesity
SALMON, T. W., & Lip, G. Y. H. (2025) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2025.2462766 · Cited by 4
Rocha, K. C. E., Tan, B., Kempf, J., Medina, C., Beldona, V., Qian, C., Duan, Y., Xiang, Q., Yoo, A., Du, X., et al. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102246 · Cited by 2
Adipogenesia, osasunaren etsai edo lagun?
Trepiana, J., Gómez-Zorita, S., Milton‐Laskibar, I., & Portillo, M. P. (2021) · EKAIA Euskal Herriko Unibertsitateko Zientzi eta Teknologi Aldizkaria · doi:10.1387/ekaia.21682 · Cited by 1
Zerk eragiten du obesitatea duen pertsona bat metabolikoki osasuntsua izatea edo ez izatea?
Rodríguez, O. A., & Eseberri, I. (2021) · EKAIA Euskal Herriko Unibertsitateko Zientzi eta Teknologi Aldizkaria · doi:10.1387/ekaia.22345
Čekić, N., Grgić, A., Kokot, A., Mujkić, R., Mujkić, D. Š., Bijelić, N., & Sablić, M. (2022) · Medicina · doi:10.3390/medicina58070854 · Cited by 1
Metabolically Healthy Obesity: An Eye-opener
Padmanabhan, P., Dinakaran, N., Verma, S., & Keerthana, S. (2022) · Gastroenterology Hepatology and Endoscopy Practice · doi:10.4103/ghep.ghep_33_22 · Cited by 1
The Effectiveness of Mindfulness-Based Cognitive Therapy (MBCT) on Sexual Self-Esteem in Obese Women
Soltanizadeh, M. (2022) · Current Research in Diabetes & Obesity Journal · doi:10.19080/crdoj.2022.15.555916 · Cited by 1
Carbohydrate, Protein, and Fat Metabolism in Obesity
Galgani, J. E., Cortés, V., & Carrasco, F. (2023) · Springer eBooks · doi:10.1007/978-3-031-40116-9_21 · Cited by 1
Skeletal Muscle Should Not Be Overlooked
Seo, J. A. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0024 · Cited by 1
Change in Metabolic Health Status Over Time and Risk of Chronic Kidney Disease: A Prospective StudyPreprint
Cui, H., Liu, Q., Wu, Y.-T., & Cao, L. (2021) · Research Square · doi:10.21203/rs.3.rs-1161519/v1
Slit3 Fragments Orchestrate Neurovascular Expansion and Thermogenesis in Brown Adipose TissuePreprint
Serdan, T. D. A., Frank, B., Cervantes, H. E., Gargey, A., Tian, Q., Hope, D., Choi, C. H. J., Hoffmann, A., Cohen, P., Blüher, M., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.24.613949 · Cited by 1
Self-citationGut microbial ecosystems differ across metabolic and obesity phenotypesPreprint
Lacruz-Pleguezuelos, B., Bazán, G. X., Romero-Tapiador, S., Freixer, G., Fernández-Cabezas, J., Aguilar-Aguilar, E., Martín‐Segura, A., Fernández, L. P., Espinosa‐Salinas, I., de Molina, A. R., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.25.650405 · Cited by 1
Hagemann, T., Sharma, A. M., Blüher, M., & Hoffmann, A. (2026) · medRxiv · doi:10.64898/2026.03.16.26348463 · Cited by 1
Self-citationChaurasiya, V., Li, L., Lluch, A., Fernández-Sánchez, A., Harju, J., Pham, D. D., Perttunen, S., Keskitalo, S., Varjosalo, M. T., Pietiläinen, K. H., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-9485802/v1 · Cited by 1
Staging Obesity Severity Delineates Metabolic Health Risks
Nadolsky, K. Z. (2020) · Obesity · doi:10.1002/oby.22939
Metadata
- Authors
- Blüher, M.
- Affiliations
- Helmholtz Munich (DE)
- Corresponding author
- Blüher, Matthias
- ORCID
- Blüher, Matthias
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2020-03-04
- Volume
- 41
- Issue
- 3
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- PMC
- PMC7098708
- OpenAlex
- W3009496837
- Cited by
- 1,090
- References
- 123
- Citations by year
- 2026: 197 · 2025: 222 · 2024: 213 · 2023: 162 · 2022: 155 · 2021: 105 · 2020: 35
- FWCI
- 86.17
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Endocrine Reviews (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Site cant be reached (submittedVersion, cc-by)
- PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion)
- Funders
- Deutsche Forschungsgemeinschaft (209933838)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Keywords
- metabolically healthy obesity, obesity, cardiometabolic risk, type 2 diabetes, cardiovascular disease, insulin sensitivity, beta-cell function, ectopic fat, visceral fat, liver fat, leg fat, cardiorespiratory fitness, weight loss, obesity treatment, risk stratification
- MeSH terms
- Obesity, Metabolically Benign, Cardiometabolic Risk Factors, Diabetes Mellitus, Type 2, Humans, Insulin Resistance, Obesity, Metabolic Syndrome, Adiposity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.